Dabigatran etexilate tetrahydrate, C34H49N7O9, has been crystallised at ambient conditions. The colourless crystal was investigated using X-ray crystallography with single crystals and powder techniques, and was characterised by thermogravimetric-differential thermal analysis (TG-DTA) and infrared spectroscopy (IR). The compound was shown to be a tetrahydrate. A dabigatran etexilate molecule and four water molecules form a large ring structure, and intra-molecular hydrogen bonds contribute to the formation of a stable molecule in the unit cell.
DasJ., and KimballS. D., Bioorg. Med. Chem., 1995, 3, 999.
10.
Food and Drug Administration, FDA Drug safety communication: update on the risk for serious bleeding events with the anticoagulant Pradaxa, 2012; http://www.fda.gov/Drugs/DrugSafety/ucm326580.htm. [accessed November 2012].
11.
BarcoS., CoppensM., van den DoolE. J., van de KerkhofD., StroobantsA. K., and MiddeldorpS., Thromb. Haemost., 2014, 112, 836.
12.
GreigS.L., and McKeageK., Drugs, 2014, 74, 1785.
13.
CalkinsH., GerstenfeldE. P., SchillingR., VermaA., and WillemsS., Am. J. Cardiol., 2015, 115, 154.
14.
LiJ., FangJ., ZhongF., LiW., TangY., XuY., MaoS., and FanG., J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci., 2014, 973, 110.
15.
WienenW., StassenJ. M., PriepkeH., RiesU. J., and HauelN., Thromb. Haemost., 2007, 98, 155.
16.
BlechS., EbnerT., Ludwig-SchwellingerE., StangierJ., and RothW., Drug Metab. Dispos., 2008, 36, 386.
17.
HuberK., ConnollyS. J., KherA., ChristoryF., DanG. A., HatalaR., KissR. G., MeierB., MerkelyB., PieskeB., PotparaT., StępińskaJ., KlunN. V., VinereanuD., and WidimskýP., Int. J. Clin. Pract., 2013, 67, 516.
18.
DavidsonT., HusbergM., JanzonM., OldgrenJ., and LevinL. A., Eur. Heart. J., 2013, 34, 177.
